FADS2 and myeloid sarcoma: Fatty acid desaturase 2 (FADS2) single nucleotide polymorphisms (SNPs) rs174611 and rs174618 are both independent protective factors of MS incidence [46], and a higher level of serum fatty acid-binding protein (FABP4) associates with more severe symptoms evaluated by EDSS score [47].